US Patent 7084243 Glucagon-like peptide-1 analogs
Patent 7084243 was granted and assigned to Eli Lilly and Company on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 24 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Nov, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+253 characters)
Article
Patent abstract
Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications at one or more of the following positions: 11, 12, 16, 22, 23, 24, 25, 27, 30, 33, 34, 35, 36, or 37. Methods of treating these GLP-1 compounds are also disclosed.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Rohn Lee Millican0
Wolfgang Glaesner0
Date of Patent
August 1, 2006
0Patent Application Number
102767720
Date Filed
June 1, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7084243 Glucagon-like peptide-1 analogs
Find more entities like US Patent 7084243 Glucagon-like peptide-1 analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.